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Spirometry Measurements During
an Episode of Exercise-Related
Transient Abdominal Pain
Darren P. Morton and Robin Callister
Purpose: To determine whether changes in lung function are associated with 
exercise-related transient abdominal pain (ETAP). Methods: Twenty-eight 
subjects susceptible to ETAP performed a  ow-volume loop before (pre) and 
after (post) treadmill exercise. Fourteen of the subjects developed symptoms of 
ETAP during the exercise and completed the  ow-volume loop while the pain 
was present. The remaining 14 subjects reported no symptoms of ETAP. Results: 
Forced inspiratory vital capacity was essentially unchanged from pre to post in 
both groups (ETAP group –0.8% ± 5.1%, comparison group –0.9% ± 6.5%). Peak 
inspiratory- ow rate increased in both the ETAP group (12.4% ± 16.2%) and the 
comparison group (17.9% ± 16.6%), but the difference between groups (–4.6%, 
standardized effect size [EF] = –0.17) was trivial. Forced expiratory vital capac-
ity decreased by approximately 4% in both groups (ETAP group –3.9% ± 3.3%, 
comparison group –4.0% ± 5.1%). Small differences in the mean change from 
pre to post between groups were recorded for peak expiratory- ow rate (–7.4%, 
EF = –0.28) and the forced expiratory volume in the  rst second of the test 
(–4.4%, EF = –0.44). Conclusions: ETAP does not appear to be associated with 
reduced inspiratory performance, suggesting that the diaphragm is not implicated 
directly in the etiology of ETAP. Expiratory power might be slightly reduced during 
an episode of ETAP, but the magnitude of this effect is unlikely to compromise 
exercise performance.
Key Words: injury management, lung function
The etiology of exercise-related transient abdominal pain (ETAP), commonly 
known as stitch or side ache, has attracted much speculation. Numerous theories 
have been proposed to explain ETAP, and recent attempts have been made to 
evaluate the integrity of the various theories.1-4 One commonly purported origin of 
the pain is the diaphragm, and indeed diaphragmatic explanations for ETAP were 
among the  rst to appear in the literature.5 Speci cally, diaphragmatic ischemia or 
cramping has been argued as the cause of ETAP.5
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In 1932, a study6 conducted at Guy·s Hospital examined diaphragm function 
while ETAP was being experienced in 4 males. Using  uoroscopic observations, 
the study reported that diaphragm function was not impaired during an episode of 
the pain. Unfortunately, no spirometry or other data from this study were presented. 
Nearly a decade later, Capps5 observed that the location of the pain was typically 
subcostal, even naming it “subcostal pain,” and on this basis, Capps asserted that 
the diaphragm was implicated. Furthermore, Capps5 argued that as the pain occurred 
during exercise it was likely to be an ischemic response. Since the work of Capps5 
until recent times, the diaphragm has been central to the proposed etiology of ETAP, 
and sports-medicine textbooks and popular publications commonly attribute the 
pain to diaphragmatic ischemia or cramping.
Recently, we provided evidence indicating that the diaphragm might not be 
involved in ETAP. The pain is not con ned to the subcostal region and can occur 
as low in the abdomen as the iliac region.2,7,8 In addition, the pain can manifest in 
activities of relatively low respiratory demand, such as horse riding2,9 and walking.8 
It is also unclear how certain factors that have been demonstrated to in uence the 
experience of the pain, such as the sugar content of  uid consumed, could relate 
to a diaphragmatic origin of the pain.10 Finally, we observed no increase in surface 
electromyographic activity at the site of ETAP during an attack, despite the instrumen-
tation being capable of measuring diaphragmatic electrophysiological output.11
The purpose of this study was to further examine the involvement of the dia-
phragm in the etiology of ETAP. We hypothesized that lung function, especially 
inspiratory performance, would be compromised during an episode of ETAP if 
the diaphragm or other muscles of respiration were involved in the etiology of 
the condition. Respiratory-muscle weakness and de ciency are known to result 
in restricted lung function, indicated particularly in measures of vital capacity.12 
Reductions in maximal  ow rates are more characteristic of obstructive disorders 
such as bronchospasm and decreased lung compliance.12 Hence, the aim of the pres-
ent study was to determine whether spirometry changes indicative of compromised 
respiratory function occur with ETAP.
Methods and Procedures
Study Design
Healthy subjects susceptible to ETAP performed a treadmill exercise session during 
which lung function was assessed using a  ow-volume loop on 2 occasions: before 
commencing exercise and after treadmill running. Before the trial the subjects 
engaged in activities designed to increase their likelihood of developing ETAP. 
Subjects who experienced ETAP during the exercise constituted the ETAP group, 
and those who did not report symptoms of the pain formed the comparison group. 
The study design allowed comparisons to be made between the 2 groups in terms 
of the pro le of change in the  ow-volume-loop measures.
Sample
Thirty- ve subjects who claimed to be susceptible to ETAP were initially recruited 
for the study and gave their written informed consent before participating. All 
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subjects were active and considered themselves to be in good physical condition. 
They reported no history of respiratory dysfunction, including asthma, and were 
free from symptoms of respiratory-tract infection and restriction at the time of the 
laboratory testing. The study was approved by the University of Newcastle Human 
Research Ethics Committee, and all research was conducted in accordance with 
this body.
Twenty-one of the 35 subjects (60%) experienced ETAP during the trial. In 
order for reliable testing to occur it was important that the subjects experience 
a “substantial” manifestation of the pain. When subjects reported symptoms of 
pain, they were asked if it was of a severity that would force them to slow down 
or stop if they were performing a recreational run. Of the 21 cases in which the 
pain manifested, 14 met this criterion. Thus, the symptomatic group comprised 14 
subjects (ETAP group), with the 7 subjects who experienced “mild” symptoms of 
ETAP being discharged from the study. The 14 subjects that did not develop the 
pain still performed the testing procedures and served as the comparison group. 
Personal details and baseline measures of the subjects are presented in Table 1. 
The variability in the manifestation of the pain called for this unconventional 
approach to allocating the subjects to the ETAP or comparison group. As seen in 
Table 1, with the exception of the comparison group having a female skew, the 
groups were not dissimilar.
Strategies to Provoke ETAP
The subjects were instructed to perform any procedures before arriving at the 
laboratory that they believed would increase their likelihood of experiencing 
Table 1 Descriptive Characteristics of Subjects and Baseline 
(Preexercise) Spirometry Measures*
ETAP
group
Comparison
group Combined
n 14 14 28
Age (y) 24.2 ± 5.8 22.2 ± 6.1  23.3 ± 5.90
Male/Female 11/3 9/5 20/8
Height (cm) 175.6 ± 9.90 172.7 ± 7.20 174.2 ± 8.6 0
Weight (kg) 66.8 ± 9.3 63.6 ± 9.7  65.2 ± 9.40
BMI (kg/m) 21.6 ± 1.8 21.2 ± 2.5  21.4 ± 2.20
FIVC (L)  4.69 ± 0.73  4.93 ± 0.77  4.81 ± 0.75
PIF (L/min)  7.50 ± 1.99  6.95 ± 2.21  7.23 ± 2.08
FEVC (L)  4.77 ± 0.80  5.02 ± 0.76  4.89 ± 0.78
PEF (L/min)  9.80 ± 3.16  9.80 ± 2.51  9.80 ± 2.80
FEV1.0 (L/min)  4.09 ± 0.55  4.10 ± 0.54  4.09 ± 0.54
*ETAP indicates exercise-related transient abdominal pain; BMI, body-mass index; FIVC, forced 
inspiratory vital capacity; PIF, peak inspiratory- ow rate; FEVC, forced expiratory vital capacity; PEF, 
peak expiratory- ow rate; FEV1.0, forced expiratory volume in the  rst second of maximal expiration. 
Data are presented as mean ± SD.
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ETAP during the testing session. For all subjects this involved consuming food 
or drink shortly before the session. Before the  rst  ow-volume loop, the sub-
jects were familiarized with the protocol and given between 200 and 500 mL of 
carbonated soft drink. The volume depended on the amount of food and drink 
already consumed by the subject. Anecdotally, soft drinks were regarded by the 
subjects as particularly provocative of ETAP, which is consistent with our recent 
 ndings.10
Laboratory Testing Protocol
After the test brie ng and  tting of a heart-rate monitor (Polar Electro Oy, Model 
45920, Finland) the subjects were familiarized with the  ow-volume-loop test by 
performing several trials. When comfortable with the procedure they completed the 
 rst test (pre). In order to derive a measure of test–retest reliability the subject then 
performed another  ow-volume loop 2 minutes later in this preexercise state. All 
measures of lung function were highly reliable (P < .01), with a mean correlation 
coef cient of .92 ± .02.
Treadmill velocity was then selected for the subjects according to their  tness 
level, with a mean velocity of 12.3 ± 1.7 km/h (range 11 to 15 km/h), which elicited 
an average heart rate of 172 ± 13 beats/min. The subjects commenced exercise 
on the treadmill at the set velocity and every 30 seconds were asked if they were 
experiencing any symptoms of ETAP. If symptoms had developed they were asked 
to rate the severity of the pain on a 10-point scale,13 from no pain (0) to pain as 
bad as it could be (10). Other measures of the pain, including its localization, posi-
tion, and sensation, were recorded. The sensation of the pain was recorded by the 
subjects choosing a descriptor from the following 5: aching, pulling, cramping, 
sharp, and stabbing. These descriptors have been shown to account for over 90% 
of ETAP pain sensations.2,7
In the subjects who developed symptoms of ETAP, the test was continued until 
the required severity was obtained. If the required pain severity was not obtained, 
the test was terminated after 15 minutes. If the required pain severity was achieved, 
the treadmill was stopped and the subjects performed the  ow-volume loop (post). 
The  ow-volume-loop test was completed within 10 to 20 seconds of the treadmill 
being stopped. On average the subjects rated the severity of ETAP as 5.1 ± 1.1 
on the numerical rating scale before stopping for the  ow-volume loop and 3.8 ± 
1.4 immediately after the spirometry test. The severity rating of the pain after the 
tests had been completed still represented a pronounced manifestation of ETAP. If 
the subjects did not develop symptoms of the pain within the  rst 8 to 10 minutes 
of the testing session, they performed the  ow-volume loop and were included as 
part of the comparison group.
Spirometry Measures
A standard  ow-volume loop was employed for this study, because it is a com-
prehensive lung-function test that assesses both expiratory and inspiratory perfor-
mance. Forced expiration relies heavily on the abdominal muscles14-16 and internal 
intercostal muscles,17 whereas forced inspiration recruits the diaphragm18-20 and 
external intercostal muscles.17
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The test was performed on a GOULD 9000 computerized pulmonary exercise 
system (GOULD, Inc, Model 229). Measures derived from the test included forced 
inspiratory vital capacity, forced expiratory vital capacity (FEVC), peak inspiratory-
 ow rate (PIF), peak expiratory- ow rate (PEF), and forced expiratory- ow rate 
in the  rst second of expiration (FEV1.0).
Statistical Analyses
For analysis, the 5 measures of lung function were expressed relative to height to 
normalize the data.12 Analysis was then completed on the log-transformed data, with 
changes expressed as percentages. A paired t test was used to determine the level of 
signi cance of within-group changes from pre to post. To assess between-groups 
effects, we used an Excel® spreadsheet prepared by Hopkins.21 The spreadsheet 
calculated the percentage change from pre to post for each subject and then per-
formed a t test to compare the mean change between the ETAP and comparison 
groups. A qualitative expression of the between-groups differences was assigned 
using a modi cation of Cohen·s effect-size classi cation system.22 The terms 
selected were trivial (0.0 to 0.2), small (0.2 to 0.6), moderate (0.6 to 1.2), large 
(1.2 to 2.0), and very large (2.0 to 4.0).
Analysis of variance (SPSS, version 11.5) was used to determine whether the 
severity of the pain was different when associated with the 5 pain descriptors used 
in the study. Reliability of the  ow-volume-loop measures was assessed using the 
Pearson correlation coef cient. Descriptive analyses involved calculating changes 
and mean ± SD. A 90% con dence interval was adopted.
Results
Characteristics of ETAP
In the group that experienced ETAP during the testing session, the pain  rst appeared 
after 2.4 ± 1.5 minutes and was deemed of suf cient severity for testing after 7.2 
± 1.8 minutes. In 1 case the subject claimed that mild pain was present after only 
30 seconds of treadmill running. In most cases the pain progressively developed 
until it achieved the desired severity, although in some instances it was completely 
relieved while the subject continued to exercise. Although it was dif cult to deter-
mine exactly, the amount of time it took after the cessation of exercise for the pain 
to completely resolve was 45 seconds to 2 minutes.
Every subject who developed ETAP described the pain as well localized. In 8 
of the 14 symptomatic cases, the pain was reported in more than 1 abdominal site, 
but the characteristics of the pain were identical in the different positions. Exactly 
half the symptomatic subjects described the pain as most severe on the right side 
of the abdomen, with the other half reporting the left side.
Only 3 of the 14 subjects who developed ETAP did not change the descriptor 
used to convey the sensation of the pain as the severity increased during the ses-
sion. ANOVA con rmed a signi cant (P < .01) difference in the severity rating 
of the descriptors. Stabbing pain was associated with signi cantly greater pain 
severity (5.3 ± 1.5) than all other terms except sharp pain (4.6 ± 1.6). Sharp 
pain was rated as more severe than aching (1.7 ± 0.9) and pulling (1.8 ± 1.2) 
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but not cramping pain (3.2 ± 1.7). There was no difference among the 3 least 
severe terms.
Spirometry
Within-group and between-groups changes in the spirometry measures are pre-
sented in Table 2. Trivial differences were observed between the groups in the 
inspiratory measures. An increase in PIF was observed in both groups. Although 
the increase in PIF was 4.6% less on average in the ETAP group, the magnitude of 
the increase was highly variable, and the effect of this difference between groups 
is unclear (Table 2).
FEVC decreased by approximately 4% in both groups, with only a trivial dif-
ference between them. Although there was considerable variability in the pre–post 
changes in PEF and FEV1.0 in both groups, on average these values tended to 
decrease in the ETAP group and increase in the comparison group. Consequently, 
there were small differences between the groups for PEF and FEV1.0.
Discussion
Characteristics of ETAP
Sinclair9 claimed that, with ingestion of food or drink before exercise, ETAP 
could be evoked in 30% to 35% of cases. In the present study ETAP was pro-
voked in 60% of cases, with 40% attaining the severity required for assessment. 
Allowing the subjects to select procedures to provoke the pain was clearly a 
successful strategy. The consumption of carbonated soft drink shortly before 
exercise appeared to be particularly provocative of ETAP, which is consistent 
with a recent report that  uids with high sugar content should be avoided by 
susceptible individuals.10 Sinclair9 observed that after ingestion, the pain pro-
gressed from the left side of the abdomen to the right side. In the present study 
there did not appear to be any pattern of progression with respect to the position 
of the pain.
The characteristics of ETAP observed in the subjects who developed the 
pain were consistent with our previous de nition of the pain,2 namely, that it 
is well localized and most prevalent in, although not con ned to, the lateral 
aspects of the midabdomen. The localized nature of the pain reported by every 
subject in the present study is noteworthy because it suggests a somatic rather 
than visceral origin.2
Although more than half the symptomatic subjects experienced ETAP in more 
than 1 position, the pain description was consistent at the different sites. This 
suggests that a common tissue is responsible for the pain, and the tissue must be 
located throughout the entire abdomen. This observation alone provides evidence 
against the pain originating from the diaphragm.
Several studies have suggested that ETAP is twice as common on the right side 
of the abdomen as on the left.2,7,9 The equal distribution of right- and left-side pain 
observed in the present study is likely a factor of the relatively small number of 
subjects. The progression from pulling or aching to stabbing pain with increasing 
severity is precisely the same as that observed in our previous work.2,7
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Breathing maneuvers including deep exhalation, forced exhalation, “belly 
breathing,” and shallow respirations have been proposed to facilitate the relief 
of ETAP.23-25 Although a decrease in pain severity was noted over the duration 
of the spirometry assessment, the pain subsides quickly when activity is ceased, 
regardless. Hence is not possible to determine from these data whether the 
breathing maneuvers of the  ow-volume loop facilitated the pain relief.
Spirometry
The present study was unconventional in its approach to measuring exercise-related 
changes in spirometry in that the posttesting occurred immediately after the sub-
ject ceased exercise so that we could take the measurements while the pain was 
present. Many studies have examined the magnitude of exercise-induced changes 
in lung function in both normal and asthmatic populations, but the convention, 
recommended by the American Thoracic Society, is to perform initial posttesting 
10 minutes after exercise has been terminated.26-28 Studies have required subjects to 
perform posttests as soon as 4 minutes after exercise,26 but immediately postexercise 
data are not available for trend comparison with the present study.
When the 10-minute postexercise protocol is adopted, decreases in spirom-
etry measures of more than 10% are typically considered functionally signi cant 
and indicative of obstructive disorders such as bronchospasm,26,28 and it has been 
suggested that this criterion should be reduced to as low as 6% to 7% for the elite 
athletic population.26,28 In neither group did the mean within-group changes in the 
present study meet either of these criteria, although 2 individuals in each group 
did. This compromise in lung function in these individuals does not appear to be 
related to the presence of ETAP because it was also observed in the comparison 
group and might simply re ect mild undiagnosed postexercise bronchospasm in 
these individuals.
In the postexercise test, both groups demonstrated a substantial increase in 
PIF and a slight decrease in FEVC. The increase in PIF could be explained by an 
increased lung compliance associated with exercise-induced surfactant production.29 
The small decrease in FEVC might have been the result of the subjects·  nding 
the  ow-volume loop challenging when performed immediately after ceasing the 
treadmill exercise. The subjects· ventilations were high at this time, and for this 
reason they found it taxing to hold the forced expiration for the 5 seconds required 
by the testing protocol.
The analyses most relevant to the primary focus of the present study are the 
comparison data between the groups because they enable the effect of ETAP to 
be elucidated. Clearly, the episode of ETAP did not result in substantial effects on 
inspiratory or expiratory capacity. Although there was an average of 4.6% differ-
ence in the increase in PIF pre–post between the groups, both groups increased 
considerably more than 4.6% from pre to post. This suggests that ETAP is unlikely 
to result in a restrictive impairment of lung function.
In terms of an obstructive respiratory disorder, the between-groups differ-
ences in the expiratory measures are of interest. Similar reductions in FEVC 
postexercise were observed in both groups, but on average, the ETAP group 
experienced a reduction in PEF and FEV1.0 after exercise, whereas the comparison 
group improved. If this is a real effect attributable to ETAP and not merely some 
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individuals experiencing mild postexercise bronchospasm, 2 explanations seem 
plausible for a possible reduction in expiratory power associated with ETAP. 
First, the pain being experienced in the ETAP group might have an effect on 
forced expiration. Immediate, sudden pain can cause acute apnea, but little 
information is available on the effect of more persistent pain on spirometry 
measures. Pain is typically associated with some pathology, and separating 
the 2 is dif cult if not impossible. The second possible explanation is that 
the mechanism responsible for ETAP imposes obstructive limitations on lung 
function. FEV1.0 and PEF can be reduced by an increase in airway resistance or 
a decrease in the lung·s elastic recoil.12 A mechanism for such acute obstruc-
tive changes is unclear, and if this is the case, it is also unclear why expiratory 
capacity (FEVC) is unaffected.
The measures of inspiratory performance were the most relevant to the primary 
aim of the present study because inspiration is dominated by diaphragm activity.18-
20 The results suggest that inspiratory performance is unlikely to be compromised 
during an episode of ETAP, indicating that diaphragm function is not substantially 
impaired during an episode of ETAP. This observation is consistent with the Guy·s 
Hospital report.6 Compromised diaphragm function would be anticipated if the 
diaphragm were anoxic or in spasm, which is commonly asserted as the mechanism 
responsible for ETAP.
Practical Applications
The following practical applications arise from the present study:
• Carbonated drinks with high sugar content appear to be highly provocative of 
ETAP. Hence, these  uids should be avoided by individuals prone to ETAP to 
reduce their likelihood of experiencing the pain. Conversely, the use of these 
 uids is of value to researchers wanting to evoke the pain for investigative 
purposes.
• Diminished exercise performance associated with ETAP is not likely the result 
of compromised lung function.
• Because diaphragm function is not substantially affected during an attack 
of ETAP, pain-management strategies speci cally designed to target the 
diaphragm are likely to be ineffective. Such procedures have included “belly 
breathing,” in which the abdomen is distended during inspiration; deep breath-
ing; and forced expiration through pursed lips. If these techniques assist with 
pain relief it would seem that their effect is for reasons other than their in u-
ence on the diaphragm.
Conclusions
The  ndings of the present study indicate that diaphragm function is unlikely to 
be compromised during an episode of ETAP, which is enlightening with respect 
to the etiology of the pain. Whether the abdominal muscles are implicated in the 
pain requires further investigation.
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